US$ 21.57
is wegovy a glp-1 drug Novo's becomes first approved for MASH Compound versions of GLP-1 drugs
Description
How might this impact on clinical practice in the foreseeable future

Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis

The plaintiffs also have accused the defendants of focusing on case-specific issues that were not expected to be part of the motion to dismiss process

GLP-1 Receptor Activation and Cardiovascular Tissue Expression The distribution of GLP-1 receptors (GLP-1R) throughout cardiovascular tissues provides the anatomical foundation for the cardioprotective effects of GLP-1 receptor agonists

Regular follow-up appointments are essential during GLP-1 therapy, typically aligning with the medication's titration schedule (often every 4 weeks initially) and as clinically indicated
